Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis

Vouk K, Katja Vouk, K Vouk, Hevir N, Neli Hevir, N Hevir, M Ribić-Pucelj, Ribić-Pucelj M, Martina Ribič-Pucelj, G. Haarpaintner, Haarpaintner G, Hagen Scherb, H Scherb, J. Osredkar, Osredkar J, Gabriele Möller, G Möller, Cornelia Prehn, C Prehn, Tea Lanišnik Rižner, Rižner TL, T Lanišnik Rižner, Jerzy Adamski, J Adamski
Human Reproduction · 2012 · vol. 27(10) , pp. 2955–2965 · doi:10.1093/humrep/des152 · PMID:22859507 · W2129793603
Other OA: bronze CC0 ⤵ 72 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study identified elevated levels of phosphatidylcholines and sphingomyelins in plasma from ovarian endometriosis patients, with a model of two lipids achieving high sensitivity and specificity for disease detection.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Current non-invasive diagnostic methods for endometriosis lack sensitivity and specificity. In search for new diagnostic biomarkers for ovarian endometriosis, we used a hypothesis-generating targeted metabolomics approach. METHODS: In a case-control study, we collected plasma of study participants and analysed their metabolic profiles. We selected a group of 40 patients with ovarian endometriosis who underwent laparoscopic surgery and a control group of 52 healthy women who underwent sterilization at the University Clinical Centre Ljubljana, Slovenia. Over 140 targeted analytes included glycerophospholipids, sphingolipids and acylcarnitines. The analytes were quantified by electrospray ionization tandem mass spectrometry. For assessing the strength of association between the metabolite or metabolite ratios and the disease, we used crude and adjusted odds ratios. A stepwise logistic regression procedure was used for selecting the best combination of biomarkers. RESULTS: Eight lipid metabolites were identified as endometriosis-associated biomarkers due to elevated levels in patients compared with controls. A model containing hydroxysphingomyelin SMOH C16:1 and the ratio between phosphatidylcholine PCaa C36:2 to ether-phospholipid PCae C34:2, adjusted for the effect of age and the BMI, resulted in a sensitivity of 90.0%, a specificity of 84.3% and a ratio of the positive likelihood ratio to the negative likelihood ratio of 48.3. CONCLUSIONS: Our results suggest that endometriosis is associated with elevated levels of sphingomyelins and phosphatidylcholines, which might contribute to the suppression of apoptosis and affect lipid-associated signalling pathways. Our findings suggest novel potential routes for therapy by specifically blocking highly up-regulated isoforms of phosphpolipase A2 and lysophosphatidylcholine acyltransferase 4.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Phosphatidylcholines Sphingomyelins Adult Adult Age Factors Age Factors Biomarkers Biomarkers Biomarkers Body Mass Index Body Mass Index Case-Control Studies Case-Control Studies Endometriosis Endometriosis Endometriosis Female Female Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (43)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:10:37.302907+00:00
License: CC0 · commercial use OK